Study wrapper · #1234
MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide.
Editor's note
This is careful mechanistic work in cells and mice from the Lee lab, and it reframes MOTS-c as an immune factor rather than a purely metabolic one, which is a genuinely new claim about mitochondrial genome function. The antibacterial and macrophage-programming results are preclinical, at doses and routes that say nothing about what subcutaneous use in humans would do. For readers following MOTS-c, the value is in the mechanism and the interferon link, not in any clinical implication.
Plain-language abstract
MOTS-c is a small peptide encoded not in the cell nucleus but in mitochondrial DNA, and it is usually discussed for its metabolic effects. This laboratory study reports that MOTS-c also behaves like a host defense peptide: it disrupted bacterial membranes, including methicillin-resistant Staphylococcus aureus, and in a mouse peritonitis model it neutralized MRSA infectivity. Immune signals such as interferon gamma raised the cells' own MOTS-c production, and adding MOTS-c to developing mouse monocytes shifted them toward macrophages with stronger bacterial clearance.